Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gavasso

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Experimental Zoology|September 14, 2001
Developmental expression of cytochrome P450 aromatase genes (CYP19a and CYP19b) in zebrafish fry (Danio rerio)J M Trant, S Gavasso, J Ackers, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 15, 2005
Comparable levels of activity and antigen in factor XII deficiency: a study of 21 homozygotes and 58 heterozygotesA Girolami, S Gavasso, E Pacquola, et al.
Thrombosis Research|September 14, 2013
Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolismC M Radu, L Spiezia, E Campello, et al.
Journal of Thrombosis and Haemostasis : JTH|November 3, 2011
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotesO Segers, P Simioni, D Tormene, et al.
Thrombosis and Haemostasis|March 1, 1996
"Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindredsP Simioni, A Scudeller, P Radossi, et al.
British Journal of Haematology|February 1, 1996
Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutationP Simioni, L Scarano, S Gavasso, et al.
International Journal of Laboratory Hematology|September 11, 2012
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosisV Rossetto, L Spiezia, M Senzolo, et al.
British Journal of Haematology|January 14, 1999
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variantP Simioni, D Tormene, D Manfrin, et al.
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort studyD Tormene, S Fortuna, G Tognin, et al.
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
Fcγ receptors in Norwegian multiple sclerosis patients and healthy controlsS Gavasso, Ø Torkildsen, T H Marøy, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Experimental Zoology|September 14, 2001
Developmental expression of cytochrome P450 aromatase genes (CYP19a and CYP19b) in zebrafish fry (Danio rerio)J M Trant, S Gavasso, J Ackers, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 15, 2005
Comparable levels of activity and antigen in factor XII deficiency: a study of 21 homozygotes and 58 heterozygotesA Girolami, S Gavasso, E Pacquola, et al.
Thrombosis Research|September 14, 2013
Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolismC M Radu, L Spiezia, E Campello, et al.
Journal of Thrombosis and Haemostasis : JTH|November 3, 2011
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotesO Segers, P Simioni, D Tormene, et al.
Thrombosis and Haemostasis|March 1, 1996
"Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindredsP Simioni, A Scudeller, P Radossi, et al.
British Journal of Haematology|February 1, 1996
Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutationP Simioni, L Scarano, S Gavasso, et al.
International Journal of Laboratory Hematology|September 11, 2012
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosisV Rossetto, L Spiezia, M Senzolo, et al.
British Journal of Haematology|January 14, 1999
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variantP Simioni, D Tormene, D Manfrin, et al.
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort studyD Tormene, S Fortuna, G Tognin, et al.
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
Fcγ receptors in Norwegian multiple sclerosis patients and healthy controlsS Gavasso, Ø Torkildsen, T H Marøy, et al.
Pageof 4